Adalimumab dose and level
| Group | Weight | No. of patients | Starting dose (mg) | Mean post induction ADA level (μg/mL) | Mean ADA level after dose increase (μg/mL) | No. of patients remaining on ADA | |
|---|---|---|---|---|---|---|---|
| A (17) | <40kg | 3 | 40/20 | 6.36 | n/a | 1 | 10 |
| 3 | 80/40 | 1 | |||||
| >40kg | 11 | 80/40 | 8 | ||||
| B (15) | <40kg | 5 | 40/20 | 4.33 | 7.15 | 3 | 7 |
| 1 | 80/40 | 1 | |||||
| >40kg | 9 | 80/40 | 3 | ||||